Global Alzheimer's Disease Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 108
Published Date: 26 Oct 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Alzheimer's Disease Diagnosis market encompasses the tools, technologies, and services used to detect and diagnose Alzheimer's disease, a progressive neurodegenerative disorder. This market includes diagnostic methods such as imaging techniques (like PET, MRI, and CT scans), biomarker testing (blood, cerebrospinal fluid, and genetic testing), cognitive assessment tools, and novel diagnostic solutions like digital health tools and AI-based diagnostics. The growing prevalence of Alzheimer’s, increasing awareness of early detection, and advancements in diagnostic technologies are driving market growth. Pharmaceutical companies, research institutions, and healthcare providers play key roles in expanding diagnostic options. However, challenges such as the high cost of advanced diagnostic tools and limited access to specialized testing in certain regions can restrain the market’s growth. The Alzheimer's Disease Diagnosis market is critical for facilitating early and accurate diagnosis, which can improve patient management and outcomes.
According to our (Global Info Research) latest study, the global Alzheimer's Disease Diagnosis market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Alzheimer's Disease Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Alzheimer's Disease Diagnosis market size and forecasts, in consumption value ($ Million), 2019-2030
Global Alzheimer's Disease Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Alzheimer's Disease Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Alzheimer's Disease Diagnosis market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alzheimer's Disease Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alzheimer's Disease Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Quanterix, Quest Diagnostics, C₂N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, EUROIMMUN Medical Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Alzheimer's Disease Diagnosis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Alzheimer's Disease Diagnosis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Neuroimaging Examination
Cerebrospinal Fluid Examination
Peripheral Blood Antibody Examination
Others
Market segment by Application
Clinical Diagnosis
Research
Market segment by players, this report covers
Roche
Quanterix
Quest Diagnostics
C₂N Diagnostics
Fujirebio
Diadem
Labcorp
Neurocode
Cognitact
EUROIMMUN Medical Diagnostics
Vazyme International
KingMed Diagnostics
Hoyotek
Carrier Biomed
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Alzheimer's Disease Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Alzheimer's Disease Diagnosis, with revenue, gross margin, and global market share of Alzheimer's Disease Diagnosis from 2019 to 2024.
Chapter 3, the Alzheimer's Disease Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Alzheimer's Disease Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Alzheimer's Disease Diagnosis.
Chapter 13, to describe Alzheimer's Disease Diagnosis research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Alzheimer's Disease Diagnosis by Type
1.3.1 Overview: Global Alzheimer's Disease Diagnosis Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Alzheimer's Disease Diagnosis Consumption Value Market Share by Type in 2023
1.3.3 Neuroimaging Examination
1.3.4 Cerebrospinal Fluid Examination
1.3.5 Peripheral Blood Antibody Examination
1.3.6 Others
1.4 Global Alzheimer's Disease Diagnosis Market by Application
1.4.1 Overview: Global Alzheimer's Disease Diagnosis Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinical Diagnosis
1.4.3 Research
1.5 Global Alzheimer's Disease Diagnosis Market Size & Forecast
1.6 Global Alzheimer's Disease Diagnosis Market Size and Forecast by Region
1.6.1 Global Alzheimer's Disease Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Alzheimer's Disease Diagnosis Market Size by Region, (2019-2030)
1.6.3 North America Alzheimer's Disease Diagnosis Market Size and Prospect (2019-2030)
1.6.4 Europe Alzheimer's Disease Diagnosis Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Alzheimer's Disease Diagnosis Market Size and Prospect (2019-2030)
1.6.6 South America Alzheimer's Disease Diagnosis Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Alzheimer's Disease Diagnosis Market Size and Prospect (2019-2030)
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Alzheimer's Disease Diagnosis Product and Solutions
2.1.4 Roche Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Quanterix
2.2.1 Quanterix Details
2.2.2 Quanterix Major Business
2.2.3 Quanterix Alzheimer's Disease Diagnosis Product and Solutions
2.2.4 Quanterix Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Quanterix Recent Developments and Future Plans
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
2.3.4 Quest Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 C₂N Diagnostics
2.4.1 C₂N Diagnostics Details
2.4.2 C₂N Diagnostics Major Business
2.4.3 C₂N Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
2.4.4 C₂N Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 C₂N Diagnostics Recent Developments and Future Plans
2.5 Fujirebio
2.5.1 Fujirebio Details
2.5.2 Fujirebio Major Business
2.5.3 Fujirebio Alzheimer's Disease Diagnosis Product and Solutions
2.5.4 Fujirebio Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fujirebio Recent Developments and Future Plans
2.6 Diadem
2.6.1 Diadem Details
2.6.2 Diadem Major Business
2.6.3 Diadem Alzheimer's Disease Diagnosis Product and Solutions
2.6.4 Diadem Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Diadem Recent Developments and Future Plans
2.7 Labcorp
2.7.1 Labcorp Details
2.7.2 Labcorp Major Business
2.7.3 Labcorp Alzheimer's Disease Diagnosis Product and Solutions
2.7.4 Labcorp Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Labcorp Recent Developments and Future Plans
2.8 Neurocode
2.8.1 Neurocode Details
2.8.2 Neurocode Major Business
2.8.3 Neurocode Alzheimer's Disease Diagnosis Product and Solutions
2.8.4 Neurocode Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Neurocode Recent Developments and Future Plans
2.9 Cognitact
2.9.1 Cognitact Details
2.9.2 Cognitact Major Business
2.9.3 Cognitact Alzheimer's Disease Diagnosis Product and Solutions
2.9.4 Cognitact Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cognitact Recent Developments and Future Plans
2.10 EUROIMMUN Medical Diagnostics
2.10.1 EUROIMMUN Medical Diagnostics Details
2.10.2 EUROIMMUN Medical Diagnostics Major Business
2.10.3 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
2.10.4 EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 EUROIMMUN Medical Diagnostics Recent Developments and Future Plans
2.11 Vazyme International
2.11.1 Vazyme International Details
2.11.2 Vazyme International Major Business
2.11.3 Vazyme International Alzheimer's Disease Diagnosis Product and Solutions
2.11.4 Vazyme International Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Vazyme International Recent Developments and Future Plans
2.12 KingMed Diagnostics
2.12.1 KingMed Diagnostics Details
2.12.2 KingMed Diagnostics Major Business
2.12.3 KingMed Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
2.12.4 KingMed Diagnostics Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 KingMed Diagnostics Recent Developments and Future Plans
2.13 Hoyotek
2.13.1 Hoyotek Details
2.13.2 Hoyotek Major Business
2.13.3 Hoyotek Alzheimer's Disease Diagnosis Product and Solutions
2.13.4 Hoyotek Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Hoyotek Recent Developments and Future Plans
2.14 Carrier Biomed
2.14.1 Carrier Biomed Details
2.14.2 Carrier Biomed Major Business
2.14.3 Carrier Biomed Alzheimer's Disease Diagnosis Product and Solutions
2.14.4 Carrier Biomed Alzheimer's Disease Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Carrier Biomed Recent Developments and Future Plans
3.1 Global Alzheimer's Disease Diagnosis Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Alzheimer's Disease Diagnosis by Company Revenue
3.2.2 Top 3 Alzheimer's Disease Diagnosis Players Market Share in 2023
3.2.3 Top 6 Alzheimer's Disease Diagnosis Players Market Share in 2023
3.3 Alzheimer's Disease Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Alzheimer's Disease Diagnosis Market: Region Footprint
3.3.2 Alzheimer's Disease Diagnosis Market: Company Product Type Footprint
3.3.3 Alzheimer's Disease Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Alzheimer's Disease Diagnosis Consumption Value and Market Share by Type (2019-2024)
4.2 Global Alzheimer's Disease Diagnosis Market Forecast by Type (2025-2030)
5.1 Global Alzheimer's Disease Diagnosis Consumption Value Market Share by Application (2019-2024)
5.2 Global Alzheimer's Disease Diagnosis Market Forecast by Application (2025-2030)
6.1 North America Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2030)
6.2 North America Alzheimer's Disease Diagnosis Market Size by Application (2019-2030)
6.3 North America Alzheimer's Disease Diagnosis Market Size by Country
6.3.1 North America Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2030)
6.3.2 United States Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
6.3.3 Canada Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
6.3.4 Mexico Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
7.1 Europe Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2030)
7.2 Europe Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2030)
7.3 Europe Alzheimer's Disease Diagnosis Market Size by Country
7.3.1 Europe Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2030)
7.3.2 Germany Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
7.3.3 France Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
7.3.5 Russia Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
7.3.6 Italy Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Alzheimer's Disease Diagnosis Market Size by Region
8.3.1 Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Region (2019-2030)
8.3.2 China Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
8.3.3 Japan Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
8.3.4 South Korea Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
8.3.5 India Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
8.3.7 Australia Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
9.1 South America Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2030)
9.2 South America Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2030)
9.3 South America Alzheimer's Disease Diagnosis Market Size by Country
9.3.1 South America Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2030)
9.3.2 Brazil Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
9.3.3 Argentina Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Alzheimer's Disease Diagnosis Market Size by Country
10.3.1 Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2030)
10.3.2 Turkey Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
10.3.4 UAE Alzheimer's Disease Diagnosis Market Size and Forecast (2019-2030)
11.1 Alzheimer's Disease Diagnosis Market Drivers
11.2 Alzheimer's Disease Diagnosis Market Restraints
11.3 Alzheimer's Disease Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Alzheimer's Disease Diagnosis Industry Chain
12.2 Alzheimer's Disease Diagnosis Upstream Analysis
12.3 Alzheimer's Disease Diagnosis Midstream Analysis
12.4 Alzheimer's Disease Diagnosis Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Alzheimer's Disease Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Alzheimer's Disease Diagnosis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Alzheimer's Disease Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Alzheimer's Disease Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Alzheimer's Disease Diagnosis Product and Solutions
Table 8. Roche Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Quanterix Company Information, Head Office, and Major Competitors
Table 11. Quanterix Major Business
Table 12. Quanterix Alzheimer's Disease Diagnosis Product and Solutions
Table 13. Quanterix Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Quanterix Recent Developments and Future Plans
Table 15. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 16. Quest Diagnostics Major Business
Table 17. Quest Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
Table 18. Quest Diagnostics Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. C₂N Diagnostics Company Information, Head Office, and Major Competitors
Table 20. C₂N Diagnostics Major Business
Table 21. C₂N Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
Table 22. C₂N Diagnostics Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. C₂N Diagnostics Recent Developments and Future Plans
Table 24. Fujirebio Company Information, Head Office, and Major Competitors
Table 25. Fujirebio Major Business
Table 26. Fujirebio Alzheimer's Disease Diagnosis Product and Solutions
Table 27. Fujirebio Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Fujirebio Recent Developments and Future Plans
Table 29. Diadem Company Information, Head Office, and Major Competitors
Table 30. Diadem Major Business
Table 31. Diadem Alzheimer's Disease Diagnosis Product and Solutions
Table 32. Diadem Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Diadem Recent Developments and Future Plans
Table 34. Labcorp Company Information, Head Office, and Major Competitors
Table 35. Labcorp Major Business
Table 36. Labcorp Alzheimer's Disease Diagnosis Product and Solutions
Table 37. Labcorp Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Labcorp Recent Developments and Future Plans
Table 39. Neurocode Company Information, Head Office, and Major Competitors
Table 40. Neurocode Major Business
Table 41. Neurocode Alzheimer's Disease Diagnosis Product and Solutions
Table 42. Neurocode Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Neurocode Recent Developments and Future Plans
Table 44. Cognitact Company Information, Head Office, and Major Competitors
Table 45. Cognitact Major Business
Table 46. Cognitact Alzheimer's Disease Diagnosis Product and Solutions
Table 47. Cognitact Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Cognitact Recent Developments and Future Plans
Table 49. EUROIMMUN Medical Diagnostics Company Information, Head Office, and Major Competitors
Table 50. EUROIMMUN Medical Diagnostics Major Business
Table 51. EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
Table 52. EUROIMMUN Medical Diagnostics Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. EUROIMMUN Medical Diagnostics Recent Developments and Future Plans
Table 54. Vazyme International Company Information, Head Office, and Major Competitors
Table 55. Vazyme International Major Business
Table 56. Vazyme International Alzheimer's Disease Diagnosis Product and Solutions
Table 57. Vazyme International Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. Vazyme International Recent Developments and Future Plans
Table 59. KingMed Diagnostics Company Information, Head Office, and Major Competitors
Table 60. KingMed Diagnostics Major Business
Table 61. KingMed Diagnostics Alzheimer's Disease Diagnosis Product and Solutions
Table 62. KingMed Diagnostics Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 63. KingMed Diagnostics Recent Developments and Future Plans
Table 64. Hoyotek Company Information, Head Office, and Major Competitors
Table 65. Hoyotek Major Business
Table 66. Hoyotek Alzheimer's Disease Diagnosis Product and Solutions
Table 67. Hoyotek Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 68. Hoyotek Recent Developments and Future Plans
Table 69. Carrier Biomed Company Information, Head Office, and Major Competitors
Table 70. Carrier Biomed Major Business
Table 71. Carrier Biomed Alzheimer's Disease Diagnosis Product and Solutions
Table 72. Carrier Biomed Alzheimer's Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 73. Carrier Biomed Recent Developments and Future Plans
Table 74. Global Alzheimer's Disease Diagnosis Revenue (USD Million) by Players (2019-2024)
Table 75. Global Alzheimer's Disease Diagnosis Revenue Share by Players (2019-2024)
Table 76. Breakdown of Alzheimer's Disease Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in Alzheimer's Disease Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 78. Head Office of Key Alzheimer's Disease Diagnosis Players
Table 79. Alzheimer's Disease Diagnosis Market: Company Product Type Footprint
Table 80. Alzheimer's Disease Diagnosis Market: Company Product Application Footprint
Table 81. Alzheimer's Disease Diagnosis New Market Entrants and Barriers to Market Entry
Table 82. Alzheimer's Disease Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Alzheimer's Disease Diagnosis Consumption Value (USD Million) by Type (2019-2024)
Table 84. Global Alzheimer's Disease Diagnosis Consumption Value Share by Type (2019-2024)
Table 85. Global Alzheimer's Disease Diagnosis Consumption Value Forecast by Type (2025-2030)
Table 86. Global Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2024)
Table 87. Global Alzheimer's Disease Diagnosis Consumption Value Forecast by Application (2025-2030)
Table 88. North America Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 89. North America Alzheimer's Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 90. North America Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 91. North America Alzheimer's Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 92. North America Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 93. North America Alzheimer's Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Europe Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 95. Europe Alzheimer's Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 96. Europe Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Europe Alzheimer's Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Europe Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 99. Europe Alzheimer's Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 106. South America Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 107. South America Alzheimer's Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 108. South America Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 109. South America Alzheimer's Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 110. South America Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Alzheimer's Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 113. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 114. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 115. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 116. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 117. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Global Key Players of Alzheimer's Disease Diagnosis Upstream (Raw Materials)
Table 119. Global Alzheimer's Disease Diagnosis Typical Customers
List of Figures
Figure 1. Alzheimer's Disease Diagnosis Picture
Figure 2. Global Alzheimer's Disease Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Alzheimer's Disease Diagnosis Consumption Value Market Share by Type in 2023
Figure 4. Neuroimaging Examination
Figure 5. Cerebrospinal Fluid Examination
Figure 6. Peripheral Blood Antibody Examination
Figure 7. Others
Figure 8. Global Alzheimer's Disease Diagnosis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Alzheimer's Disease Diagnosis Consumption Value Market Share by Application in 2023
Figure 10. Clinical Diagnosis Picture
Figure 11. Research Picture
Figure 12. Global Alzheimer's Disease Diagnosis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Alzheimer's Disease Diagnosis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Alzheimer's Disease Diagnosis Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 15. Global Alzheimer's Disease Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Alzheimer's Disease Diagnosis Consumption Value Market Share by Region in 2023
Figure 17. North America Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Alzheimer's Disease Diagnosis Revenue Share by Players in 2023
Figure 24. Alzheimer's Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 25. Market Share of Alzheimer's Disease Diagnosis by Player Revenue in 2023
Figure 26. Top 3 Alzheimer's Disease Diagnosis Players Market Share in 2023
Figure 27. Top 6 Alzheimer's Disease Diagnosis Players Market Share in 2023
Figure 28. Global Alzheimer's Disease Diagnosis Consumption Value Share by Type (2019-2024)
Figure 29. Global Alzheimer's Disease Diagnosis Market Share Forecast by Type (2025-2030)
Figure 30. Global Alzheimer's Disease Diagnosis Consumption Value Share by Application (2019-2024)
Figure 31. Global Alzheimer's Disease Diagnosis Market Share Forecast by Application (2025-2030)
Figure 32. North America Alzheimer's Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Alzheimer's Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Alzheimer's Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Alzheimer's Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Alzheimer's Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Alzheimer's Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 42. France Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Alzheimer's Disease Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 49. China Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 52. India Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Alzheimer's Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Alzheimer's Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Alzheimer's Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East & Africa Alzheimer's Disease Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Alzheimer's Disease Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 66. Alzheimer's Disease Diagnosis Market Drivers
Figure 67. Alzheimer's Disease Diagnosis Market Restraints
Figure 68. Alzheimer's Disease Diagnosis Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Alzheimer's Disease Diagnosis Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Quanterix Quest Diagnostics C₂N Diagnostics Fujirebio Diadem Labcorp Neurocode Cognitact EUROIMMUN Medical Diagnostics Vazyme International KingMed Diagnostics Hoyotek Carrier Biomed
26 Oct 2024
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
